Dongyao Ni
Senior Vice President @ AbelZeta
About
Leading the preclinical and clinical development of a series of oncolytic HSV for treatment of solid tumors.
China
Shanghai
Biotechnology
Program Management, Budget Management, 领导力, 研究, 项目管理
Experience
Senior Vice President
AbelZeta
Shanghai, China
Cell Therapy company focusing on helping patients with hematological malignancy, solid tumor and autoimmune diseases.
Chief Operating Officer
Therona
Shanghai, China
Responsible for preclinical and early clinical development of the very first circular RNA based COVID vaccine.
Chief Development Officer
深圳市亦诺微医药科技有限公司
Preclinical development of oncolytic HSV for cancer treatment.
Education
New Jersey Institute of Technology
Computational Biology
Rutgers University
Computational Biology
Dongyao Ni's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.